Chloe Baker
Impact in
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- PARP inhibition in cancer therapy 2
- HER2/EGFR in Cancer Research 1
-
- Lung Cancer Treatments and Mutations 1
- Occupational and environmental lung diseases 1
- Prostate Cancer Treatment and Research 1
- Co-authors
- Johann Sebastian De Bono (2 shared papers)Hervé Hubert (1 shared paper)Juanita Suzanne Lopez (2 shared papers)Wei Yuan (1 shared paper)Udai Banerji (2 shared papers)Sanjay Popat (1 shared paper)Ruth Riisnaes (2 shared papers)Anna Rachel Minchom (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Cancer Discovery (1 paper)European Urology (1 paper)Cancer Cell (1 paper)Journal of Evaluation in Clinical Practice (1 paper)
- Partner nations
- United KingdomGermanySpain
In The Last Decade
Chloe Baker
8 papers receiving 301 citations
Peers
Comparison fields: 5 of 32
- Oncology 137
- Pulmonary and Respiratory Medicine 114
- Cancer Research 18
- Emergency Medicine 6
- Genetics 21
Countries citing papers authored by Chloe Baker
This map shows the geographic impact of Chloe Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Baker more than expected).
Fields of papers citing papers by Chloe Baker
This network shows the impact of papers produced by Chloe Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Baker. The network helps show where Chloe Baker may publish in the future.
Co-authors
The 23 scholars most cited alongside Chloe Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 127 | |
| 2 | 2022 | 79 | |
| 3 | 2022 | 43 | |
| 4 | 2024 | 26 | |
| 5 | 2021 | 17 | |
| 6 | 2020 | 11 | |
| 7 | 2019 | 6 | |
| 8 | 2021 | 2 |
About Chloe Baker
Chloe Baker is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Emergency Medicine, Public Health, Environmental and Occupational Health and Nuclear Energy and Engineering, having authored 8 papers that have together received 311 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), PARP inhibition in cancer therapy (2 papers), Lung Cancer Treatments and Mutations (1 paper), Ethics in Clinical Research (1 paper), Occupational and environmental lung diseases (1 paper), Cardiac Arrest and Resuscitation (1 paper), HER2/EGFR in Cancer Research (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Oncology (137 citations), Pulmonary and Respiratory Medicine (114 citations), Cancer Research (18 citations), Emergency Medicine (6 citations) and Genetics (21 citations). Chloe Baker has collaborated with scholars based in United Kingdom, Germany and Spain. Frequent co-authors include Johann Sebastian De Bono, Hervé Hubert, Juanita Suzanne Lopez, Wei Yuan, Udai Banerji, Sanjay Popat, Ruth Riisnaes, Anna Rachel Minchom, Suzanne Carreira and Joséphine Escutnaire. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Discovery, European Urology, Cancer Cell and Journal of Evaluation in Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.